NDI 1150-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NDI 1150-101, covering 2024-11-25 to 2024-11-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of NDI 1150-101 in Patients With Solid Tumors [Phase 1, Phase 2]